Zimmer Biomet Inc.

ZBH | NYSE

Price Alert Chart Builder DCF Calculator

$94.32

-$1.04 (-1.09%)

At close: Sep 21, 2026, 4:00 PM ET

$94.32

$0 (0.00%)

After-hours: Sep 21, 2026, 4:08 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Market Data

Market Cap $18.45B

Enterprise Value $25.32B

Beta 0.47

Average Volume 2.26M

Shares Outstanding (Diluted) 192.8M

Shares Change YoY -2.77%

Institutional Ownership 98.65%

Exchange NYSE

ISIN US98956P1021

Price Performance

Price Change 1M -7.1%

Price Change 3M 7.7%

Price Change 6M 7.6%

Price Change YTD 4.8%

Price Change 1Y -7.3%

Price Change 3Y -19.3%

Price Change 5Y -35.7%

1M CAGR (ann.) -1.9%

1Y CAGR (ann.) -3.6%

5Y CAGR (ann.) -6.1%

All-Time CAGR 2.2%

Valuation

PE Ratio 22.95

Forward PE 10.17

PEG Ratio 95.13

Forward PEG 3.68

PS Ratio 2.14

Forward PS 2.00

PB Ratio 1.45

P/FCF Ratio 8.10

P/Adj. FCF Ratio 8.56

P/OCF Ratio 10.40

EV/Sales 2.98

EV/EBIT 20.60

EV/EBITDA 12.93

EV/FCF 11.23

Earnings Yield 4.4%

FCF Yield 12.3%

Adj. FCF Yield 11.7%

Financial Health

Net Debt $7.07B

Total Debt $7.48B

Cash & Short-Term Investments $410M

Total Assets $22.8B

Current Ratio 1.69

Quick Ratio 1.69

Debt / Equity Ratio 0.59

Debt / EBITDA 3.82

Debt / FCF 3.32

OCF / Debt 0.28

Interest Coverage 4.63

Altman Z-Score 2.48

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 69.9%

Operating Profit Margin 15.7%

EBITDA Margin 23.0%

Net Profit Margin 9.5%

FCF Margin 26.5%

Adj. FCF Margin 25.1%

SBC / Revenue 1.1%

SBC Impact (per share) -5.4%

Returns

Return on Assets 3.5%

Return on Equity 6.4%

Return on Invested Capital 5.5%

Return on Capital Employed 6.8%

Return on Tangible Assets 9.6%

Historical Growth (CAGR)

Revenue CAGR 3Y 5.8%

Revenue CAGR 5Y 2.9%

Revenue CAGR 10Y 1.2%

EPS CAGR 3Y 19.5%

EPS CAGR 5Y -1.2%

EPS CAGR 10Y 14.1%

FCF CAGR 3Y 29.8%

FCF CAGR 5Y 11.0%

FCF CAGR 10Y 8.9%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 42

EPS Growth Next 3Y 36.2%

Revenue Growth Next 3Y 4.3%

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number $77.96

Graham Upside -17.4%

Lynch Fair Value $20.55

Lynch Upside -78.2%

Price Target $103.11

Price Target Upside 9.3%

Cash Flow

Operating Cash Flow $2.1B

Free Cash Flow $2.25B

Adj. Free Cash Flow $2.13B

FCF Per Share $9.52

OCF Per Share $9.07

OCF/S Ratio 20.5%

Income Statement

Revenue $8.51B

Gross Profit $5.95B

Operating Income $1.34B

EBITDA $1.96B

Net Income $806.8M

EPS (Diluted) $4.11

Revenue / Employee $500.52K

Profit / Employee $47.46K

Employees 17,000

Dividends

Annual Dividend $0.96

Dividend Yield 1.02%

Payout Ratio 23.4%

FCF Payout Ratio 10.4%

Adj. FCF Payout Ratio 11.0%

Dividend Growth (YoY) 0.0%

Pay Frequency Quarterly

Ex-Dividend Date Sep 29, 2026